Securities Lawsuit Filed Against Alto Neuroscience, Inc.

Investors in Alto Neuroscience, Inc. were notified by Levi & Korsinsky, LLP of a class action securities lawsuit alleging securities fraud. The lawsuit claims that the Company made false statements about its product pipeline, ALTO-100, being less effective in treating major depressive disorder than defendants had led investors to believe. This led to the Company's public statements being materially false and misleading at all relevant times. Investors who purchased Alto common stock or securities between February 2, 2024 and October 22, 2024, may be entitled to compensation without payment of any out-of-pocket costs or fees.

Key Takeaways:

  • The lawsuit alleges that Alto Neuroscience, Inc. made false statements about its product pipeline, ALTO-100, being less effective in treating major depressive disorder.
  • The Company's public statements were allegedly materially false and misleading at all relevant times.
  • The lawsuit covers investors who purchased Alto common stock or securities between February 2, 2024 and October 22, 2024.
  • Levi & Korsinsky, LLP is representing the investors and has secured hundreds of millions of dollars for aggrieved shareholders in the past 20 years.
  • The firm has a team of over 70 employees and extensive expertise representing investors in complex securities litigation.
  • Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States for seven years in a row.

Statistics:

  • The lawsuit covers a period of approximately 8 months, from February 2, 2024 to October 22, 2024.
  • The amount of compensation available to investors is not specified in the press release.
  • The number of employees at Levi & Korsinsky, LLP is over 70.
  • The firm has secured hundreds of millions of dollars for aggrieved shareholders over the past 20 years.
  • The number of years the firm has ranked in ISS Securities Class Action Services' Top 50 Report is 7.

Sources:

  • PRNewswire, "Levi & Korsinsky, LLP Notifies Investors in Alto Neuroscience, Inc. of Class Action Securities Lawsuit" (PRNewswire, August 8, 2025)
  • Levi & Korsinsky, LLP, "Alto Neuroscience, Inc. Securities Class Action Lawsuit" (Levi & Korsinsky, LLP, August 8, 2025)